Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL
Alexandra Schrader(University of Cologne), Marco Herling(Unknown)
Cited by 105
Related Papers
CD4+/CD56+ Hematodermic Tumor
|American Journal of Clinical Pathology|2007|172
Consensus criteria for diagnosis, staging, and treatment response assessment of T-cell prolymphocytic leukemia
|Blood|2019|161
JAK/STAT-Activating Genomic Alterations Are a Hallmark of T-PLL
|Cancers|2019|66
Proteogenomics refines the molecular classification of chronic lymphocytic leukemia
|Nature Communications|2022|42